FAE.MC : Summary for FAES FARMA, S.A. - Yahoo Finance

U.S. Markets closed

Faes Farma, S.A. (FAE.MC)


MCE - MCE Delayed Price. Currency in EUR
Add to watchlist
3.33-0.04 (-1.19%)
At close: 5:35PM CET
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.37
Open3.36
Bid3.32 x 373800
Ask3.36 x 30000
Day's Range3.32 - 3.38
52 Week Range2.41 - 3.80
Volume174,471
Avg. Volume269,651
Market Cap859.64M
BetaN/A
PE Ratio (TTM)23.79
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Faes Farma SA : Neutral assessment on price but strong on fundamentals
    Capital Cube8 months ago

    Faes Farma SA : Neutral assessment on price but strong on fundamentals

    Faes Farma SA relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 63.Our analysis is based on comparing Faes Farma SA with the following peers – Laboratorios Farmaceuticos Rovi, S.A., Almirall SA and Grifols, S.A. Class B (ROVI-ES, ALM-ES and GRF.P-ES).Relative ValuationFaes Farma SA is currently neutrally […] (Read more...) The post Faes Farma SA : Neutral assessment on price but strong on fundamentals appeared first on CapitalCube.

  • Faes Farma SA : Overvalued relative to peers, but may deserve another look
    Capital Cubelast year

    Faes Farma SA : Overvalued relative to peers, but may deserve another look

    Faes Farma SA relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 50.Our analysis is based on comparing Faes Farma SA with the following peers – Laboratorios Farmaceuticos Rovi, S.A., Almirall SA and Grifols, S.A. Class B (ROVI-ES, ALM-ES and GRF.P-ES).Relative ValuationFaes Farma SA’s price of EUR […] (Read more...) The post Faes Farma SA : Overvalued relative to peers, but may deserve another look appeared first on CapitalCube.

  • Faes Farma SA : Fairly valued, but don’t skip the other factors
    Capital Cubelast year

    Faes Farma SA : Fairly valued, but don’t skip the other factors

    Faes Farma SA relative valuation is now NEUTRAL. It was previously rated UNDERVALUED, and has a fundamental analysis score of 50.Our analysis is based on comparing Faes Farma SA with the following peers – Laboratorios Farmaceuticos Rovi, S.A., Almirall SA and Grifols, S.A. Class B (ROVI-ES, ALM-ES and GRF.P-ES).Relative ValuationFaes Farma SA is currently neutrally […] (Read more...) The post Faes Farma SA : Fairly valued, but don’t skip the other factors appeared first on CapitalCube.